BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 11, 2008
View Archived Issues
Indibulin well tolerated, active in patients with advanced solid tumors
Read More
DTS-108 may represent an improvement over irinotecan
Read More
Abacavir, didanosine linked to increased risk of myocardial infarction
Read More
Nebicapone increases levodopa exposure in Parkinson's disease patients
Read More
PHX-1149 effective in proof-of-concept study in type 2 diabetes patients
Read More
Collegium filed supplemental NDA for approval of AllerNase for allergic rhinitis
Read More
Phase I study of ENMD-2076 begins in advanced cancer patients
Read More
Otelixizumab set to enter phase III for new-onset type 1 diabetes
Read More
Cationorm launched in France for dry eye symptoms
Read More
Novel CGRP antagonist profiled at Merck & Co.
Read More
Iomai receives grant to develop patch-based anthrax vaccine
Read More
Critical Therapeutics completes phase I clinical trial of (R)-zileuton
Read More
Exubera labeling updated in the United States
Read More
Seattle Genetics initiates phase Ib clinical trial of SGN-40 in non-Hodgkin's lymphoma
Read More
Novartis' ACZ-885 shows potential in treating serious life-long autoinflammatory conditions
Read More
Teverelix LA demonstrates testosterone suppression in prostate cancer study
Read More
BGC-20-0166 shows potential for obstructive sleep apnea
Read More
OVax cleared to begin phase I/II trial in ovarian cancer
Read More
Aerosolized ALN-RSV01 begins phase II trial in adult RSV
Read More
Pivotal phase III trial commences for novel cancer agent ASA-404
Read More
FDA approves Lexiscan as an agent in myocardial perfusion imaging
Read More
Crucell enters research license agreement with Celltrion to evaluate Star production technology
Read More
FDA extends action date for priority review of Amgen's BLA for romiplostim in ITP
Read More
Recent patents disclose novel antidiabetic agents
Read More